[Featured Stock] Selbion Surges Over 60% on First Day of KOSDAQ Listing

Selbion is showing a sharp rise on its first day listed on the KOSDAQ market.

As of 9:15 a.m. on the 16th, Selbion is trading at 25,150 won, up 10,150 won (67.67%) from the public offering price of 15,000 won.

Founded in 2010, Selbion is a company that produces radiopharmaceuticals and diagnostic agents, and is currently developing a prostate cancer treatment called 'Lu-177-DGUL'.

Earlier, Selbion set its public offering price at 15,000 won, exceeding the upper limit of the expected price range (10,000 to 12,200 won) during the demand forecast conducted for institutional investors from the 24th to the 30th of last month. Subsequently, in the general subscription held on the 7th and 8th, it recorded a competition rate of 1,065.46 to 1, with approximately 3.8177 trillion won in subscription deposits collected.

This content was produced with the assistance of AI translation services.